NEWARK, CA / ACCESS Newswire / January 7, 2026 / Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") today ...
Under the agreement, Etienna Bio has obtained exclusive global rights to intellectual property covering human adipose-derived progenitor cells combined with an adipose-derived hydrogel matrix, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback